Skip to main content
Premium Trial:

Request an Annual Quote

GeneNews Raises $1.5M in Private Placement

NEW YORK (GenomeWeb News) – GeneNews this week said that it had closed the first tranche of a private placement offering of its common shares, raising C$1.7 million (US$1.5 million).

The Toronto-based firm issued around 6.8 million common shares at a price of C$.25 per share. It plans to use the proceeds to support continued marketing of its ColonSentry test in Canada, and for pre-launch activities for the test in the US, Europe, and Asia.

Earlier this year, GeneNews raised around C$1.8 million through two private placement tranches of convertible secured debentures.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.